Recent insider trading activity from KENYON LAWRENCE A, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 26, 2024 | Outlook Therapeutics, Inc. | $OTLK | KENYON LAWRENCE A | Chief Financial Officer | P | Common Stock | 5000 | $5.69 | 5,946.0000 | 25,476,438 | 528.54% | 0.02% |
| March 20, 2024 | Outlook Therapeutics, Inc. | $OTLK | KENYON LAWRENCE A | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 13,012,833 | 9999.99% | 0.10% |